Rhythm Pharmaceuticals (RYTM) Change in Account Payables (2016 - 2017)
Rhythm Pharmaceuticals (RYTM) posted quarterly Change in Account Payables of -$105000.0 for Q1 2017, up 82.76% quarter-over-quarter from -$609000.0 in Q4 2016.
Rhythm Pharmaceuticals (RYTM) Change in Account Payables (2016 - 2017) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Change in Account Payables for 2 consecutive years, with -$105000.0 the latest figure, recorded in Q1 2017.
- In Q1 2017, Change in Account Payables changed N/A year-over-year to -$105000.0; the TTM figure through Dec 2017 stood at -$105000.0 (changed N/A YoY), while the FY2017 annual figure was -$105000.0, up 77.66% from the prior year.
- Change in Account Payables improved to -$105000.0 in Q1 2017 per RYTM's latest filing, from -$609000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at -$105000.0 in Q1 2017 and bottomed at -$609000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -105,000.00 |
| Mar 31, 2017 | -105,000.00 |
| Dec 31, 2016 | -609,000.00 |
| Dec 31, 2016 | -609,000.00 |